Review





Similar Products

90
Solae LLC soy-based autoprobiotic supro plus 2640 ds
Dynamics of dyspepsia severity according to the GIS scale in patients with CRC after intake of indigenous enterococci. Notes: V1—before <t>autoprobiotic</t> consumption, V2—after autoprobiotic consumption.
Soy Based Autoprobiotic Supro Plus 2640 Ds, supplied by Solae LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/supro+plus+2640/supro++plus+2640+ds/pmc11124500-62-4-9
Average 90 stars, based on 1 article reviews
soy-based autoprobiotic supro plus 2640 ds - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Monsanto Company supro plus 2640
Dynamics of dyspepsia severity according to the GIS scale in patients with CRC after intake of indigenous enterococci. Notes: V1—before <t>autoprobiotic</t> consumption, V2—after autoprobiotic consumption.
Supro Plus 2640, supplied by Monsanto Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/supro+plus+2640/supro+plus+2640/pm36013992-62-8-15
Average 90 stars, based on 1 article reviews
supro plus 2640 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Solae LLC supro® plus 2640 ds
Dynamics of dyspepsia severity according to the GIS scale in patients with CRC after intake of indigenous enterococci. Notes: V1—before <t>autoprobiotic</t> consumption, V2—after autoprobiotic consumption.
Supro® Plus 2640 Ds, supplied by Solae LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/supro+plus+2640/supro++plus+2640+ds/us09034402-39-44-23
Average 90 stars, based on 1 article reviews
supro® plus 2640 ds - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Dynamics of dyspepsia severity according to the GIS scale in patients with CRC after intake of indigenous enterococci. Notes: V1—before autoprobiotic consumption, V2—after autoprobiotic consumption.

Journal: Microorganisms

Article Title: Autoprobiotics in the Treatment of Patients with Colorectal Cancer in the Early Postoperative Period

doi: 10.3390/microorganisms12050980

Figure Lengend Snippet: Dynamics of dyspepsia severity according to the GIS scale in patients with CRC after intake of indigenous enterococci. Notes: V1—before autoprobiotic consumption, V2—after autoprobiotic consumption.

Article Snippet: Patients consumed a soy-based autoprobiotic (SUPRO PLUS 2640 DS, “Solae”, Zwaanhofweg, Belgium) containing 5 × 10 8 CFU/mL autoprobiotic enterococci at a dose of 100 mL per day (50 mL twice a day) for 10 days.

Techniques:

The average results of the GSRS questionnaire in dynamics before and after  autoprobiotic  intake.

Journal: Microorganisms

Article Title: Autoprobiotics in the Treatment of Patients with Colorectal Cancer in the Early Postoperative Period

doi: 10.3390/microorganisms12050980

Figure Lengend Snippet: The average results of the GSRS questionnaire in dynamics before and after autoprobiotic intake.

Article Snippet: Patients consumed a soy-based autoprobiotic (SUPRO PLUS 2640 DS, “Solae”, Zwaanhofweg, Belgium) containing 5 × 10 8 CFU/mL autoprobiotic enterococci at a dose of 100 mL per day (50 mL twice a day) for 10 days.

Techniques: Reflux

Changes in serum levels of IL-6 ( a ) and IL-18 ( b ) before and after autoprobiotic administration. Note: Data are presented in pmol per 1 L. V1—before autoprobiotic consumption, V2—after autoprobiotic consumption. The upper norm limit for IL-6 is 7 pmol per 1 L, and for IL-18 it is 100 pmol per 1 L.

Journal: Microorganisms

Article Title: Autoprobiotics in the Treatment of Patients with Colorectal Cancer in the Early Postoperative Period

doi: 10.3390/microorganisms12050980

Figure Lengend Snippet: Changes in serum levels of IL-6 ( a ) and IL-18 ( b ) before and after autoprobiotic administration. Note: Data are presented in pmol per 1 L. V1—before autoprobiotic consumption, V2—after autoprobiotic consumption. The upper norm limit for IL-6 is 7 pmol per 1 L, and for IL-18 it is 100 pmol per 1 L.

Article Snippet: Patients consumed a soy-based autoprobiotic (SUPRO PLUS 2640 DS, “Solae”, Zwaanhofweg, Belgium) containing 5 × 10 8 CFU/mL autoprobiotic enterococci at a dose of 100 mL per day (50 mL twice a day) for 10 days.

Techniques:

Quantitative content of E. faecalis ( A ) and E. faecium or E. hirae ( B ) before and after administration of autoprobiotics in the early postoperative period. Note: V1—before autoprobiotic consumption, V2—after autoprobiotic consumption.

Journal: Microorganisms

Article Title: Autoprobiotics in the Treatment of Patients with Colorectal Cancer in the Early Postoperative Period

doi: 10.3390/microorganisms12050980

Figure Lengend Snippet: Quantitative content of E. faecalis ( A ) and E. faecium or E. hirae ( B ) before and after administration of autoprobiotics in the early postoperative period. Note: V1—before autoprobiotic consumption, V2—after autoprobiotic consumption.

Article Snippet: Patients consumed a soy-based autoprobiotic (SUPRO PLUS 2640 DS, “Solae”, Zwaanhofweg, Belgium) containing 5 × 10 8 CFU/mL autoprobiotic enterococci at a dose of 100 mL per day (50 mL twice a day) for 10 days.

Techniques:

Quantitative content of atypical E. coli ( a ) and typical E. coli ( b ) before and after administration of autoprobiotics in the postoperative period. Note: V1—before autoprobiotic consumption, V2—after autoprobiotic consumption.

Journal: Microorganisms

Article Title: Autoprobiotics in the Treatment of Patients with Colorectal Cancer in the Early Postoperative Period

doi: 10.3390/microorganisms12050980

Figure Lengend Snippet: Quantitative content of atypical E. coli ( a ) and typical E. coli ( b ) before and after administration of autoprobiotics in the postoperative period. Note: V1—before autoprobiotic consumption, V2—after autoprobiotic consumption.

Article Snippet: Patients consumed a soy-based autoprobiotic (SUPRO PLUS 2640 DS, “Solae”, Zwaanhofweg, Belgium) containing 5 × 10 8 CFU/mL autoprobiotic enterococci at a dose of 100 mL per day (50 mL twice a day) for 10 days.

Techniques:

Quantitative content of Bifidobacterium spp. before and after administration of autoprobiotics in the postoperative period. Note: V1—before autoprobiotic consumption, V2—after autoprobiotic consumption.

Journal: Microorganisms

Article Title: Autoprobiotics in the Treatment of Patients with Colorectal Cancer in the Early Postoperative Period

doi: 10.3390/microorganisms12050980

Figure Lengend Snippet: Quantitative content of Bifidobacterium spp. before and after administration of autoprobiotics in the postoperative period. Note: V1—before autoprobiotic consumption, V2—after autoprobiotic consumption.

Article Snippet: Patients consumed a soy-based autoprobiotic (SUPRO PLUS 2640 DS, “Solae”, Zwaanhofweg, Belgium) containing 5 × 10 8 CFU/mL autoprobiotic enterococci at a dose of 100 mL per day (50 mL twice a day) for 10 days.

Techniques:

Lactobacillus spp. ( a ), Enterococcus spp. ( b ), Parvimonas micra ( c ), Enterobacter spp. ( d ), Clostridium perfringens ( e ), and Akkermansia muciniphila ( f ) quantitative content in the fecal samples of patients with CRC before and after therapy. Note: V1—before autoprobiotic consumption, V2—after autoprobiotic consumption.

Journal: Microorganisms

Article Title: Autoprobiotics in the Treatment of Patients with Colorectal Cancer in the Early Postoperative Period

doi: 10.3390/microorganisms12050980

Figure Lengend Snippet: Lactobacillus spp. ( a ), Enterococcus spp. ( b ), Parvimonas micra ( c ), Enterobacter spp. ( d ), Clostridium perfringens ( e ), and Akkermansia muciniphila ( f ) quantitative content in the fecal samples of patients with CRC before and after therapy. Note: V1—before autoprobiotic consumption, V2—after autoprobiotic consumption.

Article Snippet: Patients consumed a soy-based autoprobiotic (SUPRO PLUS 2640 DS, “Solae”, Zwaanhofweg, Belgium) containing 5 × 10 8 CFU/mL autoprobiotic enterococci at a dose of 100 mL per day (50 mL twice a day) for 10 days.

Techniques:

Alpha-biodiversity before and after therapy in the level of class. Note: V1—before autoprobiotic consumption, V2—after autoprobiotic consumption.

Journal: Microorganisms

Article Title: Autoprobiotics in the Treatment of Patients with Colorectal Cancer in the Early Postoperative Period

doi: 10.3390/microorganisms12050980

Figure Lengend Snippet: Alpha-biodiversity before and after therapy in the level of class. Note: V1—before autoprobiotic consumption, V2—after autoprobiotic consumption.

Article Snippet: Patients consumed a soy-based autoprobiotic (SUPRO PLUS 2640 DS, “Solae”, Zwaanhofweg, Belgium) containing 5 × 10 8 CFU/mL autoprobiotic enterococci at a dose of 100 mL per day (50 mL twice a day) for 10 days.

Techniques: